TP53 and glioblastoma: Analyzing the postmortem sample tissue of GBM patients, patients who received TMZ treatment for more than half a year also had p53 overexpression, implying that p53 expression could predict the outcomes of patients receiving TMZ chemotherapy for a long time (Malkoun et al., 2012).